Acuta Capital Partners, LLC Iovance Biotherapeutics, Inc. Call Options Transaction History

Acuta Capital Partners, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2018 Aug 15, 2018	SELL	$12.45 - $16.95 $165,585 - $225,435	-13,300 Reduced 6.54%	190,000 $2.43 Million
Q1 2018 May 15, 2018	BUY	$8.1 - $19.5 $1.56 Million - $3.75 Million	192,300 Added 1748.18%	203,300 $3.44 Million
Q4 2017 Feb 14, 2018	BUY	$6.65 - $9.25 $73,150 - $101,750	11,000	11,000 $88,000

320

238M

1.27M

1.68M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.74B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Acuta Capital Partners, LLC with notifications on news.